Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Escherichia coli outer membrane proteins (OMPs) and strain-specific surface receptors are critical components of the Gram-negative bacterial cell envelope, serving as the primary interface between the bacterium and its environment [3, 12]. This group includes general porins like OmpC and OmpF, which facilitate the diffusion of small molecules, and structural proteins like OmpA that maintain membrane integrity and mediate host cell adhesion [8, 12, 15]. Specialized complexes such as the Bam (beta-barrel assembly machine) and Lpt (lipopolysaccharide transport) systems are essential for the biogenesis of the outer membrane itself [4, 5]. Pathogenic strains often express unique surface receptors, such as intimin or fimbrial proteins, which are vital for tissue-specific colonization and virulence [6, 10]. As surface-exposed molecules, these proteins are prime targets for therapeutic intervention, including the development of narrow-spectrum antibiotics, vaccines, and bacteriophage therapies [1, 6, 18]. Targeting these proteins can disrupt essential transport processes, compromise the bacterial permeability barrier, or prevent infection by blocking adhesion to host tissues [4, 5, 19]. However, the high conservation of many OMPs across different E. coli strains poses a challenge for maintaining the health of the commensal gut microbiota [1].
Inhibition of outer membrane biogenesis (e.g., BamA and LptD inhibition), disruption of the bacterial cell membrane integrity, and neutralization of virulence-associated adhesion to host tissues [4, 5, 6].
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli outer membrane proteins and related strain-specific surface receptors (E. coli OMPs).